Latest Biotech News

Researchers at the Spanish National Cancer Research Centre and collaborators developed genomic tests harnessing chromosomal instability (CIN) signatures to predict patient resistance to multiple...

Innovations in molecular imaging have emerged with development of novel PET tracers enhancing cancer diagnosis. Shandong Cancer Hospital introduced a peptide-based tracer outperforming ^18F-FDG in...

Artificial intelligence continues to reshape biotech and healthcare domains. Michigan State University researchers combined nanomedicine and AI to detect rare cancer biomarkers, improving early...

Notable neuroscience advances include detailed mapping of native calcium-permeable AMPA receptors critical to cerebellum function, providing therapeutic avenues to repair injury-induced...

San Diego-based Cidara Therapeutics reported highly favorable results from its randomized, double-blind, placebo-controlled Phase IIb Navigate trial, testing the long-acting antiviral biologic...

Illumina announced its definitive agreement to acquire proteomics technology company SomaLogic from Standard BioTools for an upfront $350 million in cash plus up to $75 million in near-term...

Amid ongoing leadership turmoil at the U.S. Food and Drug Administration, Jacqueline Corrigan-Curay, acting director of the Center for Drug Evaluation and Research (CDER), announced her upcoming...

Researchers have made strides in molecular imaging with new positron emission tomography (PET) tracers targeting immune checkpoint proteins PD-L1 and glypican-3 (GPC3) in cancers. The...

Vertex Pharmaceuticals’ cell therapy zimislecel showed promising Phase 1/2 results in type 1 diabetes, with most patients achieving insulin independence and controlled blood glucose one year...

An international collaboration led by the Spanish National Cancer Research Centre and partners at Cambridge and Tailor Bio has developed a novel genomic test leveraging chromosomal instability...

Medical technology innovations are advancing airway management with robotic intubation systems and AI-powered anatomical recognition, promising improvements in accuracy and patient safety during...

Washington University researchers developed Cirrus, an AI-driven resting state fMRI software approved by the FDA, that accelerates neurosurgical brain mapping by producing detailed functional...

Recent developments in oncology include a phase 3 trial where Roche’s combination of bispecific antibody Lunsumio and antibody-drug conjugate Polivy significantly improved progression-free...

Cidara Therapeutics reported positive Phase 2b results for its long-acting antiviral biologic CD-388, designed to prevent seasonal influenza in healthy adults aged 18 to 64. The single-dose...

The FDA is undergoing significant leadership turnover with Jacqueline Corrigan-Curay, acting head of the Center for Drug Evaluation and Research (CDER), announcing her retirement in July. This...

Illumina has agreed to acquire SomaLogic from Standard BioTools for up to $425 million. The acquisition expands Illumina’s capabilities in proteomics and enhances its multiomics strategy by...

Roche demonstrated a phase 3 trial success combining the CD20xCD3 bispecific antibody Lunsumio with the antibody-drug conjugate Polivy to treat large B-cell lymphoma (LBCL) patients ineligible for...

Emerging studies leverage AI to enhance medical diagnostics and predictive modeling. One demonstrates that deep learning models incorporating knee alignment significantly improve predictions of...

New high-density neural recording technologies enable brain-wide, real-time monitoring of tens of thousands of neurons in awake primates, providing unprecedented resolution of neural dynamics...

Recent data highlight progress in diabetes and obesity treatments. Vertex Pharmaceuticals’ cell therapy zimislecel shows promising Phase 1/2 results enabling insulin independence in type 1...